✦ LIBER ✦

Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 AS04 Adjuvanted Vaccine in Healthy Males Aged 10–18 Years

✍ Scribed by M. Lehtinen; T. Petäjä; H. Keränen; T. Karppa; A. Kawa; S. Lantela; H. Levänen; T. Tocklin; O. Godeaux; G. Dubin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity and Safety of Human Papil

✍ Tiina Petäjä; Heli Keränen; Tiina Karppa; Anna Kawa; Sirkku Lantela; Mari Siitar 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 414 KB

Immunogenicity and safety of human papil

✍ Neerja Bhatla; Vanita Suri; Partha Basu; Surendra Shastri; Sanjoy K. Datta; Dan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 977 KB

Immunogenicity and tolerability of an HP

✍ Tino F. Schwarz; Marek Spaczynski; Achim Schneider; Jacek Wysocki; Andrzej Galaj 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 653 KB

Efficacy of the human papillomavirus (HP

✍ A. Szarewski; W.A.J. Poppe; S.R. Skinner; C.M. Wheeler; J. Paavonen; P. Naud; J. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 857 KB

Safety and Immunogenicity of the HPV-16/

✍ Doris M. Rivera Medina; Alejandra Valencia; Alet de Velasquez; Li-Min Huang; Rom 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Randomized Trial: Immunogenicity and Saf

✍ Court Pedersen; Morten Breindahl; Naresh Aggarwal; Johan Berglund; György Oroszl 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 389 KB